{
    "clinical_study": {
        "@rank": "134654", 
        "arm_group": {
            "arm_group_label": "GLP-1", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This study aims to assess the effect of glucagon-like peptide-1 on cardiac output and\n      transpulmonary gradient in patients undergoing right heart catheterisation for clinical\n      reasons."
        }, 
        "brief_title": "The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart Failure", 
        "condition": "Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age over 18\n\n          -  Able to give informed consent\n\n          -  On the waiting list for heart transplant\n\n          -  Left Ventricular Dysfunction awaiting catheterisation\n\n        Exclusion Criteria:\n\n          -  Nicorandil, glibenclamide, Dipeptidyl Peptidase-4 inhibitor, Glucagon-Like Peptide-1\n             receptor agonist or insulin\n\n          -  Women of child bearing age and breast feeding women\n\n          -  Cardiac pacemaker or other implanted metallic device\n\n          -  Unable to give informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 30, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02129179", 
            "org_study_id": "PO1860"
        }, 
        "intervention": {
            "arm_group_label": "GLP-1", 
            "intervention_name": "Glucagon-Like Peptide 1", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Glucagon", 
                "Glucagon-Like Peptide 1"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 1, 2014", 
        "location": {
            "contact": {
                "last_name": "Parameshwar", 
                "phone": "01480 830541"
            }, 
            "facility": {
                "address": {
                    "city": "Papworth Everard", 
                    "country": "United Kingdom", 
                    "zip": "CB23 3RE"
                }, 
                "name": "Papworth Hospital NHS Foundation Trust"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart Failure", 
        "overall_contact": {
            "last_name": "Jayan Parameshwar", 
            "phone": "01480 830541"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "United Kingdom: National Health Service", 
                "United Kingdom: Research Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in Pulmonary Vascular Resistance with Glucagon-Like Peptide-1", 
            "safety_issue": "No", 
            "time_frame": "30 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02129179"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Papworth Hospital NHS Foundation Trust", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Papworth Hospital NHS Foundation Trust", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}